Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06277999 · ClinicalTrials.gov registry record
C.Difficile Observational Study
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 7
- Enrollment target
NCT06277999: Completed study, sponsored by AstraZeneca.
NCT06277999 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06277999 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
D8820C00001 is an exploratory, non-interventional, unblinded, observational study evaluating the acceptability, feasibility and performance of methods to collect, transport and test biospecimens in participants ≥ 18 years of age with an active CDI. Participants will also be monitored for recurring episodes of diarrhea and will need to complete validated PROs and study evaluation questionnaires
Primary Outcome
Evaluation of the overall and individual completion rate of procedures and logistics involved in key study activities defined as: * Stool sample collection, transport, and processing. * Serum collection. * Identification of suspected rCDI using the participant monitoring strategy * Cdiff32, CDI-DaySyms and PGI-S PRO questionnaire completion rate during the SOC treatment period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2024-12-17 |
What the finished NCT06277999 record still lists
NCT06277999 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06277999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06277999 about?
NCT06277999 is a clinical study titled "C.Difficile Observational Study". D8820C00001 is an exploratory, non-interventional, unblinded, observational study evaluating the acceptability, feasibility and performance of methods to collect, transport and test biospecimens in participants ≥ 18 years of age with an active CDI. Participants will also be monitored for recurring e...
What is the current status of trial NCT06277999?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2024-04-22. Estimated completion is 2024-12-17.
Who is sponsoring clinical trial NCT06277999?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI